Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Gimeracil/oteracil/tegafur

Diarrhoea, heart failure and interstitial pneumonia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kobayashi K, et al. Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study. BMC Cancer 22 : 1028, No. 1, Dec 2022. Available from: URL: https://bmccancer.biomedcentral.com/ Kobayashi K, et al. Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study. BMC Cancer 22 : 1028, No. 1, Dec 2022. Available from: URL: https://​bmccancer.​biomedcentral.​com/​
Metadaten
Titel
Gimeracil/oteracil/tegafur
Diarrhoea, heart failure and interstitial pneumonia
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54871-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Metformin

Case report

Multiple drugs

Case report

Antiepileptics